MAPKAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.977800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.847700E-02
Normal-vs-Stage2
7.852300E-02
Normal-vs-Stage3
5.531700E-02
Normal-vs-Stage4
1.175190E-01
Stage1-vs-Stage2
4.278200E-01
Stage1-vs-Stage3
6.402000E-01
Stage1-vs-Stage4
3.839800E-01
Stage2-vs-Stage3
1.994770E-01
Stage2-vs-Stage4
6.989200E-01
Stage3-vs-Stage4
2.411000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.821800E-02
Normal-vs-AfricanAmerican
1.617590E-01
Normal-vs-Asian
3.000600E-01
Caucasian-vs-AfricanAmerican
5.016600E-01
Caucasian-vs-Asian
4.685400E-01
AfricanAmerican-vs-Asian
9.401000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.228200E-02
Normal-vs-Female
7.670000E-02
Male-vs-Female
5.725200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.425800E-02
Normal-vs-Age(41-60Yrs)
1.442230E-01
Normal-vs-Age(61-80Yrs)
4.919600E-02
Normal-vs-Age(81-100Yrs)
9.734000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.827900E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.556200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.031600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.097700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.707400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.799400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.519700E-02
Normal-vs-Daily Drinker
2.239700E-02
Normal-vs-Weekly Drinker
3.445800E-01
Normal-vs-Occasional Drinker
9.788300E-02
Normal-vs-Social Drinker
1.494960E-01
Non Drinker-vs-Daily Drinker
6.945000E-01
Non Drinker-vs-Weekly Drinker
7.620200E-02
Non Drinker-vs-Occasional Drinker
2.024000E-01
Non Drinker-vs-Social Drinker
4.314000E-02
Daily Drinker-vs-Weekly Drinker
1.405040E-01
Daily Drinker-vs-Occasional Drinker
3.500600E-01
Daily Drinker-vs-Social Drinker
7.948300E-02
Weekly Drinker-vs-Occasional Drinker
5.104600E-01
Weekly Drinker-vs-Social Drinker
9.637600E-01
Occasional Drinker-vs-Social Drinker
4.471800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.677400E-01
Normal-vs-Grade 2
9.003000E-01
Normal-vs-Grade 3
9.127600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.817010E-01
Grade 1-vs-Grade 3
3.285000E-01
Grade 1-vs-Grade 4
9.677400E-01
Grade 2-vs-Grade 3
7.590200E-01
Grade 2-vs-Grade 4
9.003000E-01
Grade 3-vs-Grade 4
9.127600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.665800E-02
Normal-vs-NonDiabetic
6.440200E-02
Diabetic-vs-NonDiabetic
7.872800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.179040E-01
Normal-vs-NoPancreatitis
5.599800E-02
Pancreatitis-vs-NoPancreatitis
6.056000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.639500E-02
Normal-vs-N1
7.360000E-02
N0-vs-N1
6.555400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.829900E-02
Normal-vs-TP53-NonMutant
7.904400E-02
TP53-Mutant-vs-TP53-NonMutant
4.840800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
